Coss, Christopher C.
Jones, Amanda
Dalton, James T.
Article History
Received: 15 March 2016
Accepted: 14 April 2016
First Online: 22 April 2016
Compliance with ethical standards
:
: These studies were funded by GTx, Inc.Robert Wills Ph. D., Mary-Ann Johnston PharmD, and Michael Mohler PharmD, Ph.D. are all employees of GTx Inc. and provided assistance with manuscript preparation.Open access publication of this manuscript was sponsored by drug company GTx, Inc.
: Drs. Coss, Jones and Dalton are all former employees of GTx, Inc. Drs. Jones and Dalton are GTx-024 inventors. Dr. Dalton receives royalties through the University of Tennessee Research Foundation as an inventor of GTx-024 and is a paid consultant to GTx, Inc. The views expressed do not represent the views of the Agency or the United States.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.